April 25, 2023
Holland & Knight Health Dose: April 25, 2023
![Holland & Knight Health Dose](/-/media/images/twittercards/blogs/healthdose.png?rev=28e9e198d69c446c9fd8409f368b8252&sc_lang=en&hash=7A2FDB35CB2B5C08E70E64C1347FE915)
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- House E&C Turns its Attention to Transparency and Competition
- Senate Committee on HELP Sets Sights on PBMs and Insulin Pricing
- Senate Finance Also Charging Ahead on PBMs
- House Committee on Energy and Commerce Holds Hearing on Healthcare Workforce
- CMS Issues 2024 Notice of Benefit and Payment Parameters Final Rule
- White House May Nominate Dr. Monica Bertagnolli To Be New NIH Director
- Supreme Court Rules on Abortion Drug Access